Kaletra (Lopinavir/ritonavir)

lopinavir/ritonavir · Abbott Laboratories

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Kaletra (Lopinavir/ritonavir), covering 2015-05-19 to 2017-05-11. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB [Phase 4]

See pricing